Visipaque 320 and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Visipaque 320 (iodixanol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month and have Kidney stones.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Visipaque 320. It is created by eHealthMe based on reports of 111 people who have side effects when taking Visipaque 320 from the FDA, and is updated regularly.

What is Visipaque 320?

Visipaque 320 has active ingredients of iodixanol. eHealthMe is studying from 112 Visipaque 320 users. Check the latest studies of Visipaque 320.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,314 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

111 people reported to have side effects when taking Visipaque 320.
Among them, 14 people (12.61%) have Dyspnea exacerbated.

Could Visipaque 320 cause Dyspnea exacerbated?

Among these 14 people:

How long have people been on Visipaque 320 when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Visipaque 320? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Dyspnea exacerbated when taking Visipaque 320? *

What are other side effects people have besides Dyspnea exacerbated? *

Skin Blushing/flushing (a sudden reddening of the face, neck): 3 people, 21.43%
Itching: 2 people, 14.29%
Rashes (redness): 2 people, 14.29%
Chest Pain: 2 people, 14.29%
Back Pain: 2 people, 14.29%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 1 person, 7.14%
Oxygen Saturation Decreased: 1 person, 7.14%
Nausea And Vomiting: 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Throat Tightness: 1 person, 7.14%

What are the existing conditions these people have? *

Kidney Stones: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Visipaque 320 and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Visipaque 320:

Visipaque 320 (112 reports)

Browse all side effects of Visipaque 320:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,314 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iodixanol (the active ingredients of Visipaque 320) and Visipaque 320 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.